The Dow Jones Industrial Average closed up more than 500 points on Tuesday after news that biotech company Novavax had begun human trials for a potential COVID-19 vaccine and more parts of the US and several European economies reopening after lockdowns.
The Dow closed just shy of 25,000 on Tuesday, for a time crossing what analysts have identified as an important psychological barrier to economic recovery after the coronavirus pandemic.
On Tuesday morning, vaccine maker Novavax announced it had begun phase 1 clinical trials of a potential COVID-19 vaccine by giving 130 healthy adult volunteers in Australia two doses of the drug, called NVX-CoV2373. Other firms, including Pfizer and Moderna, are also racing to develop a vaccine.
Over the weekend, several restrictions to regular economic activity put into place to prevent the spread of COVID-19 began to be lifted in Italy, Spain, and the United States, and the United Kingdom announced future plans for how such a reopening work unfold. The WSJ noted that bookings for hotels and airline flights were increasing.
Sourse: sputniknews.com
0.00 (0%) 0 votes
MOSCOW (Sputnik) - The Coalition for the Restoration of Democracy (CORED), which unites 18 opposition parties in Guinea, said on…
The news of an interplanetary scale comes after NASA believed it had captured its first sample with Perseverance last month,…
MOSCOW (Sputnik) - The last pipe of the second string of Nord Stream 2 has been welded, and after a…
LONDON (Sputnik) – The UK government on Monday condemned the military coup against the president of Guinea, Alpha Conde, and…